Unlike with MAPT and C9orf72 mutations, FTD-related GRN mutations are almost exclusively loss-of-function, making progranulin replacement an attractive and conceptually straightforward therapeutic strategy. The gene discussed is C9orf72; the disease is frontotemporal dementia.